CPRX : Summary for Catalyst Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

Catalyst Pharmaceuticals, Inc. (CPRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.70+0.02 (+1.19%)
At close: 4:00PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close1.68
Bid1.63 x 10000
Ask1.74 x 5000
Day's Range1.62 - 1.73
52 Week Range0.51 - 1.81
Avg. Volume1,051,303
Market Cap141.05M
PE Ratio (TTM)-7.80
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Accesswire5 days ago

    Financials of Aurinia Pharmaceuticals and Catalyst Pharmaceuticals are Getting Stability

    NEW YORK, NY / ACCESSWIRE / March 21, 2017 / Both companies achieved their stability in different ways, but still achieved the same end. That achievement was reflected in their rise in stock prices at ...

  • Catalyst Pharmaceuticals Inc (CPRX): Here’s What’s Next
    Insider Monkey10 days ago

    Catalyst Pharmaceuticals Inc (CPRX): Here’s What’s Next

    After struggling throughout the latter half of 2016 with various development and regulatory pressures, Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) has finally found some reprieve. Said reprieve comes in the form of some data just put out relating to the company’s lead development candidate (although not related to said candidate’s lead indication directly) and Catalyst is running […]

  • Associated Press11 days ago

    Catalyst reports 4Q loss

    On a per-share basis, the Coral Gables, Florida-based company said it had a loss of 5 cents. For the year, the company reported that its loss widened to $18.1 million, or 22 cents per share. In the final ...